Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
about
Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic DisordersInflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory diseaseIncretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart diseaseGlucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesImpact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective studySitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemIncretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryExendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes.Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.The pathophysiology of hypertension in patients with obesity.Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands.Altered immune regulation in type 1 diabetes.Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.Clinical challenges: Myeloma and concomitant type 2 diabetes.Clinical challenges: myeloma and concomitant type 2 diabetesTreatment of diabetes with glucagon-like peptide-1 gene therapy.Is there a role for the incretin system in blood pressure regulation?Mechanisms for the cardiovascular effects of glucagon-like peptide-1.Chronic critical illness: the price of survival.Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis.Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.Nutrition, inflammation and liver-spleen axis.Multiple myeloma and diabetes.Essay for the 2011 CIHR/CMAJ award: glucagon-like peptides for metabolic and gastrointestinal disorders.iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 TherapyThe effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.Effects of Incretin-Based Therapies on Diabetic Microvascular Complications.Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).Inflammation and incretins.Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques.Role of Incretin Axis in Inflammatory Bowel Disease.
P2860
Q26740443-E32C1FB6-1821-4F0B-9D65-1A98BC9CC9DEQ26752511-73AB5B87-026E-4743-BE98-03BCC80A14EAQ26778350-62B9030C-9DFB-4E6F-975F-4591012FE559Q26784211-22CB0ABB-E947-4D49-98E3-6988C48B2288Q28067465-15483EAA-52F4-415D-8BCD-35C791980DF5Q33754087-43879671-A6E3-4F6F-9A36-B6A7EC68D987Q33930280-5B99BB94-652F-4491-96BF-DFF1AA239F7EQ34062829-ECB5F35E-53F2-446C-943A-BE19ADA5F861Q34362412-200EE448-5E7A-4945-BB8F-3845F96DFF0CQ34603269-CBCEFCCE-672C-416E-9D95-996E2D678A1EQ34718822-CC52FF4D-6C76-4B95-B10E-B8F9ED0C6EA8Q35021492-F5A92BD3-2A35-498D-8B3B-9AE3783E0F1DQ35285238-2650835D-A01F-48A5-825D-53E466D2A780Q36249780-AF4B0E12-B05C-474D-BDC5-FA04A52E8E04Q36296760-5F51DC8A-0196-4BDD-97FF-2413CA445446Q36422653-1DBC8F1E-33DA-4726-8334-D6003A898625Q37095161-1E8FB3BE-3FD3-4483-A22C-39391CE186DEQ37122842-7227723E-F4C1-4261-BEFE-5CBFB80A0D52Q37148578-890C152A-EC2E-4DCF-9589-5D7E8BCF8433Q37193295-24C4DD33-FF31-462D-A57E-6AA43AAF3517Q37258157-4A16D0F1-8C76-4740-9A75-1BB5902B4C9BQ37467309-740F4CCE-97EC-460D-8007-737A4860AD2BQ37552667-63D68F36-4765-4F1E-AB37-95BE8F6C9D75Q37804398-01C5A4B5-4725-427F-8920-87FC8E3D937CQ38182499-8D788E0B-F0CE-4DF7-9726-66FCE8EB393DQ38589032-9AECAD7E-8C57-4C63-BE43-2EAEA2C57107Q38628366-9D6A7858-E773-4DC4-823A-103CBB92CCF1Q38753804-FE195A97-11EC-4B89-8BAC-A5324D6DA07CQ39103371-B9CCE89A-8DC3-4EAF-8729-F58F445E8645Q40074896-D17BEEDA-2987-4B92-B1A9-7FEDDF4F6057Q40086170-45EAA8BC-74E0-496B-B4F8-7FC2126062CFQ40550022-2CA7BB0A-7A4B-43F7-8586-E38AA523F3AFQ40889860-834C5B0F-07ED-48B0-83CB-8884E5D69EDDQ41440576-8621D00A-67DB-491E-AC88-E0C0E7BF2AACQ42118961-3CC6E1F6-6FDD-4D3C-BAEF-6E741D783C08Q42366423-98462706-AC4D-409E-B2EA-B2F6CC9E45F0Q42371744-2BCF78F7-4BA0-4AF0-94E8-A163AF740758Q43224035-FB1926CA-9E8D-4883-9D40-732D18F23534Q44120881-645B6BEA-AE60-4F0A-85F6-B676AE4CFC35Q47103249-29B6E981-9BF0-4F91-B20C-32DE5D16C302
P2860
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@ast
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@en
type
label
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@ast
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@en
prefLabel
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@ast
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@en
P2093
P2860
P3181
P1433
P1476
Glucagon-like peptide-1 recept ...... peripheral regulatory T cells
@en
P2093
D. J. Drucker
I. Hadjiyanni
J. S. Danska
K. A. Siminovitch
P2860
P2888
P304
P3181
P356
10.1007/S00125-009-1643-X
P577
2010-01-08T00:00:00Z
P5875
P6179
1015411126